[Silent myocardial ischemia during hemodialysis in patients with chronic renal insufficiency]. 1991

G Pochmalicki, and F Jan, and I Fouchard, and E Teiger, and A Benmaadi, and C Buisson, and C Boesch, and G Rostoker
Service de Cardiologie, Hôpital Henri Mondor, Creteil.

A prospective search for episodes of silent myocardial ischaemia (SMI) was carried out during sessions of haemodialysis in 62 patients with chronic renal failure and was positive in 37.1% of the cases. The occurrence of SMI is correlated with the number of cardiovascular risk factors (p = 0.008) and particularly with diabetes (p = 0.012), smoking (p = 0.007) and age (p = 0.02), as well as with the type of nephropathy that had caused the renal failure (p = 0.02). During a 6-month follow-up two patients died; both had silent myocardial ischaemia on Holter recordings. In these anaemic patients, haemodialysis might sensitize the detection of ischaemia by the concomitant occurrence of hypotensive, hypovolaemic or hypoxic episodes, thus playing a aggravating role. The existence of such episodes characterizes a subgroup of patients at high cardiovascular risk for whom the prognosis and the best therapeutic approach remain to be determined.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

G Pochmalicki, and F Jan, and I Fouchard, and E Teiger, and A Benmaadi, and C Buisson, and C Boesch, and G Rostoker
May 2000, Renal failure,
G Pochmalicki, and F Jan, and I Fouchard, and E Teiger, and A Benmaadi, and C Buisson, and C Boesch, and G Rostoker
April 1996, Medical journal, Armed Forces India,
G Pochmalicki, and F Jan, and I Fouchard, and E Teiger, and A Benmaadi, and C Buisson, and C Boesch, and G Rostoker
January 2012, La Revue du praticien,
G Pochmalicki, and F Jan, and I Fouchard, and E Teiger, and A Benmaadi, and C Buisson, and C Boesch, and G Rostoker
December 1996, Vnitrni lekarstvi,
G Pochmalicki, and F Jan, and I Fouchard, and E Teiger, and A Benmaadi, and C Buisson, and C Boesch, and G Rostoker
January 1986, Urologiia i nefrologiia,
G Pochmalicki, and F Jan, and I Fouchard, and E Teiger, and A Benmaadi, and C Buisson, and C Boesch, and G Rostoker
March 1986, Revista medica de Chile,
G Pochmalicki, and F Jan, and I Fouchard, and E Teiger, and A Benmaadi, and C Buisson, and C Boesch, and G Rostoker
January 1994, Gaceta medica de Mexico,
G Pochmalicki, and F Jan, and I Fouchard, and E Teiger, and A Benmaadi, and C Buisson, and C Boesch, and G Rostoker
January 1970, Annales de biologie clinique,
G Pochmalicki, and F Jan, and I Fouchard, and E Teiger, and A Benmaadi, and C Buisson, and C Boesch, and G Rostoker
May 1985, Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology,
G Pochmalicki, and F Jan, and I Fouchard, and E Teiger, and A Benmaadi, and C Buisson, and C Boesch, and G Rostoker
June 1986, Klinicheskaia meditsina,
Copied contents to your clipboard!